Table 4.

Association between peripheral neuropathy and HIV/AIDS clinical factors in South Gondar Zone public health institutions, 2020, Ethiopia.

Variable	Peripheral sensory neuropathy		Total (n = 555)	Bivariable logistic regression
	Yes (n = 179)	No (n = 376)		p value	COR (95% CI)
Presence of co morbid DM
Yes	24	19	43	0.001	2.9 (1.5,5.4)
No	155	357	512		1.0
Duration of disease
<2	28	44	72		1.0
2–5	67	160	227	0.13*	0.6 (0.38,1.14)
>5	84	172	256	0.33	0.7 (0.4,1.3)
Current CD4 count
<200	23	32	55	0.08*	0.59 (0.3,1.06)
201–350	91	214	305	0.02*	0.3 (0.14.0.65)
351–500	15	69	84	0.69*	1.1 (0.6,2.2)
>500	50	61	111		1.0
Viral load(copies/ul)
<50	6	52	58		1.0
50–1000	100	229	329	0.009*	1.6 (1.1,2.8)
>1000	73	95	168	0.000*	2.04 (1.01,4.02)
Comorbid HTN
Yes	22	52	74	0.62	0.87 (0.5,1.4)
No	157	324	481		1.0
Stage of the disease
Stage I	95	181	276		1.0
Stage II	36	79	115	0.55*	1.15 (0.72,1.83)
Stage III	30	80	110	0.82*	1.46 (0.46,2.46)
Stage IV	18	36	54	0.79*	1.7 (0.55,2.2)

HTN = Hypertension, DM = Diabetes Mellitus, HAART = Highly Active Anti-Retroviral Therapy * p value < 0.25.